HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Nafarelin (Synarel)

A potent synthetic agonist of GONADOTROPIN-RELEASING HORMONE with 3-(2-naphthyl)-D-alanine substitution at residue 6. Nafarelin has been used in the treatments of central PRECOCIOUS PUBERTY and ENDOMETRIOSIS.
Also Known As:
Synarel; Nafarelin Acetate; Nafarelin Acetate, Hydrate; Nafarelin Monoacetate; RS-94991-298; RS 94991 298; RS94991298; Luteinizing hormone-releasing factor (pig), 6-(3-(2-naphthalenyl)-D-alanine)-
Networked: 118 relevant articles (22 outcomes, 27 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Bergqvist, A: 2 articles (07/2001 - 12/2000)
2. Brown, Julie: 1 article (01/2015)
3. Farquhar, Cynthia: 1 article (01/2015)
4. Brinker, Allen: 1 article (05/2013)
5. Avigan, Mark: 1 article (05/2013)
6. Gatti, Jasmine: 1 article (05/2013)
7. Riggs, M M: 1 article (01/2012)
8. Martin, S W: 1 article (01/2012)
9. van der Graaf, P H: 1 article (01/2012)
10. Bennetts, M: 1 article (01/2012)

Related Diseases

1. Endometriosis (Adenomyosis)
2. Pelvic Pain
3. Leiomyoma (Uterine Fibroids)
4. Hirsutism
5. Hot Flashes

Related Drugs and Biologics

1. Gonadotropin-Releasing Hormone (GnRH)
2. Danazol (Azol)
3. Nafarelin (Synarel)
4. Norethindrone (Norethisterone)
5. Leuprolide (Lupron)
6. Oral Contraceptives
7. Androgens
8. Hemoglobins (Hemoglobin)
9. Buserelin (Suprefact)
10. Hormones

Related Therapies and Procedures

1. Aftercare (After-Treatment)
2. Retreatment
3. Hysterectomy
4. Laparotomy
5. Intranasal Administration